logo
Plus   Neg
Share
Email

Novartis: CHMP Adopts Positive Opinion For Beovu - Quick Facts

Novartis (NVS) announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for Beovu, an investigational product for the treatment of wet age-related macular degeneration. The positive CHMP opinion is based on findings from the Phase III, global, head-to-head HAWK and HARRIER clinical trials.

The final decision from the European Commission on the marketing authorization for Beovu is expected within three months.

In October 2019, Novartis received the first approval for Beovu from the U.S. FDA in the treatment of wet age-related macular degeneration.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement. Gap Inc. partnered with fashion resale platform thredUP to facilitate the exchange of secondhand cloths. The retailer in a blog post said its customers can bring secondhand clothes in exchange for shopping credit that can be redeemed at Gap, Banana Republic, Athleta, or Janie and Jack. Customers who redeem their credits at Gap brands will receive an additional 15 percent payout bonus. Coca-Cola Co. (KO) on Friday reaffirmed its guidance for the full-year 2020 and provided an update on the expected impact from COVID-19 on first quarter 2020 results, ahead of its presentation at the Consumer Analyst Group of New York (CAGNY) Conference. For fiscal 2020, the company continues to project...
Follow RTT
>